|
MYADM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59601237676088E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-14 |
| Normal-vs-Stage2 |
1.592390E-02 |
| Normal-vs-Stage3 |
2.72599999995293E-06 |
| Normal-vs-Stage4 |
5.610900E-04 |
| Stage1-vs-Stage2 |
6.067800E-02 |
| Stage1-vs-Stage3 |
4.398900E-04 |
| Stage1-vs-Stage4 |
1.238410E-04 |
| Stage2-vs-Stage3 |
9.241400E-01 |
| Stage2-vs-Stage4 |
6.414000E-01 |
| Stage3-vs-Stage4 |
5.086200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.79376521916674E-12 |
| Normal-vs-AfricanAmerican |
2.464500E-03 |
| Normal-vs-Asian |
5.489900E-02 |
| Caucasian-vs-AfricanAmerican |
4.729800E-01 |
| Caucasian-vs-Asian |
5.822000E-01 |
| AfricanAmerican-vs-Asian |
2.690200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.81320008691466E-10 |
| Normal-vs-Female |
2.37809771874709E-11 |
| Male-vs-Female |
3.305900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.235820E-03 |
| Normal-vs-Age(41-60Yrs) |
1.24260046696634E-10 |
| Normal-vs-Age(61-80Yrs) |
3.80749998196706E-09 |
| Normal-vs-Age(81-100Yrs) |
3.067900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.030000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.411850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.413600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.738400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.820000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.825800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.522800E-03 |
| Normal-vs-Grade 2 |
3.51940698806175E-13 |
| Normal-vs-Grade 3 |
2.15929999991538E-07 |
| Normal-vs-Grade 4 |
2.296000E-03 |
| Grade 1-vs-Grade 2 |
5.550300E-02 |
| Grade 1-vs-Grade 3 |
4.486400E-02 |
| Grade 1-vs-Grade 4 |
1.349630E-02 |
| Grade 2-vs-Grade 3 |
1.114220E-02 |
| Grade 2-vs-Grade 4 |
7.518300E-02 |
| Grade 3-vs-Grade 4 |
9.311000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.90769622321341E-12 |
| Normal-vs-ccB subtype |
3.53679999998135E-06 |
| ccA subtype-vs-ccB subtype |
1.421560E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.97389995646591E-09 |
| Normal-vs-N1 |
7.100300E-02 |
| N0-vs-N1 |
4.350200E-02 |
|
|
